Updated
NovaBridge BiosciencesNBP · Healthcare
$0.91+0.22%
Market cap$102M
IndustryBiotechnology

NovaBridge Biosciences (NBP) Superinvestor holders

5 of the superinvestors we track hold NovaBridge Biosciences (NBP) in their latest 13F filings, $17M in total.

Summary

The largest holder is Zhang Lei (Hillhouse (HHLR Advisors)), with $12M, 1.4% of the portfolio.

In their latest quarter: 3 opened a new position, 1 added.

Who holds it

Each investor's latest 13F filing, largest stake first. What a 13F shows.

InvestorLast changeSharesValue% of portfolioFiled for
Zhang Lei
Hillhouse (HHLR Advisors)
Held 5,980,568$12M 1.4%Q2 2026
Paul Marshall
Marshall Wace
New position 1,231,946$2M 0.0%Q2 2026
Two Sigma
Two Sigma Investments
New position 851,348$2M 0.0%Q2 2026
Jim Simons
Renaissance Technologies
Added 758,226$1M 0.0%Q2 2026
Acadian
Acadian Asset Management
New position 98,344$131,000 0.0%Q3 2026

Holders by quarter

QuarterSuperinvestors holding it
Q2 20264
Q1 20263
Q4 20252
Q3 20253
Q2 20253
Q1 20253
Q4 20243
Q3 20243

Questions about NovaBridge Biosciences

Which superinvestors own NovaBridge Biosciences?

5 of the superinvestors we track hold NovaBridge Biosciences (NBP) in their latest 13F filings, $17M in total. Zhang Lei, Paul Marshall, Two Sigma, Jim Simons, Acadian.

Who is the largest superinvestor holder of NBP?

The largest holder is Zhang Lei (Hillhouse (HHLR Advisors)), with $12M, 1.4% of the portfolio.

From NovaBridge Biosciences's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.

Investingly

Better research starts here.

Every filing, chart and insider trade behind NovaBridge Biosciences and thousands of other companies, in one place. Free to start.